These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 11205902)

  • 21. Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance.
    Imai Y; Tsukahara S; Asada S; Sugimoto Y
    Cancer Res; 2004 Jun; 64(12):4346-52. PubMed ID: 15205350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and functional analyses of breast cancer resistance protein in lung cancer.
    Kawabata S; Oka M; Soda H; Shiozawa K; Nakatomi K; Tsurutani J; Nakamura Y; Doi S; Kitazaki T; Sugahara K; Yamada Y; Kamihira S; Kohno S
    Clin Cancer Res; 2003 Aug; 9(8):3052-7. PubMed ID: 12912956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2.
    Kowalski P; Stein U; Scheffer GL; Lage H
    Cancer Gene Ther; 2002 Jul; 9(7):579-86. PubMed ID: 12082458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative analysis of breast cancer resistance protein and cellular resistance to flavopiridol in acute leukemia patients.
    Nakanishi T; Karp JE; Tan M; Doyle LA; Peters T; Yang W; Wei D; Ross DD
    Clin Cancer Res; 2003 Aug; 9(9):3320-8. PubMed ID: 12960118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane.
    Rocchi E; Khodjakov A; Volk EL; Yang CH; Litman T; Bates SE; Schneider E
    Biochem Biophys Res Commun; 2000 Apr; 271(1):42-6. PubMed ID: 10777678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined effects of multiple flavonoids on breast cancer resistance protein (ABCG2)-mediated transport.
    Zhang S; Yang X; Morris ME
    Pharm Res; 2004 Jul; 21(7):1263-73. PubMed ID: 15290869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure.
    Komatani H; Kotani H; Hara Y; Nakagawa R; Matsumoto M; Arakawa H; Nishimura S
    Cancer Res; 2001 Apr; 61(7):2827-32. PubMed ID: 11306452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Broad-spectrum modulation of ATP-binding cassette transport proteins by the taxane derivatives ortataxel (IDN-5109, BAY 59-8862) and tRA96023.
    Minderman H; Brooks TA; O'Loughlin KL; Ojima I; Bernacki RJ; Baer MR
    Cancer Chemother Pharmacol; 2004 May; 53(5):363-9. PubMed ID: 15060738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug-resistant proteins in breast cancer: recent progress in multidrug resistance].
    Wu DL; Huang F; Lu HZ
    Ai Zheng; 2003 Apr; 22(4):441-4. PubMed ID: 12704006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric analysis of breast cancer resistance protein expression and function.
    Minderman H; Suvannasankha A; O'Loughlin KL; Scheffer GL; Scheper RJ; Robey RW; Baer MR
    Cytometry; 2002 Jun; 48(2):59-65. PubMed ID: 12116365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein.
    Minderman H; O'Loughlin KL; Pendyala L; Baer MR
    Clin Cancer Res; 2004 Mar; 10(5):1826-34. PubMed ID: 15014037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein.
    Rabindran SK; Ross DD; Doyle LA; Yang W; Greenberger LM
    Cancer Res; 2000 Jan; 60(1):47-50. PubMed ID: 10646850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.
    Ross DD; Yang W; Abruzzo LV; Dalton WS; Schneider E; Lage H; Dietel M; Greenberger L; Cole SP; Doyle LA
    J Natl Cancer Inst; 1999 Mar; 91(5):429-33. PubMed ID: 10070941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecin.
    Rajendra R; Gounder MK; Saleem A; Schellens JH; Ross DD; Bates SE; Sinko P; Rubin EH
    Cancer Res; 2003 Jun; 63(12):3228-33. PubMed ID: 12810652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C.
    Rabindran SK; He H; Singh M; Brown E; Collins KI; Annable T; Greenberger LM
    Cancer Res; 1998 Dec; 58(24):5850-8. PubMed ID: 9865745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines.
    Scheffer GL; Maliepaard M; Pijnenborg AC; van Gastelen MA; de Jong MC; Schroeijers AB; van der Kolk DM; Allen JD; Ross DD; van der Valk P; Dalton WS; Schellens JH; Scheper RJ
    Cancer Res; 2000 May; 60(10):2589-93. PubMed ID: 10825126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Novel Benzamide Derivative, VKNG-2, Restores the Efficacy of Chemotherapeutic Drugs in Colon Cancer Cell Lines by Inhibiting the ABCG2 Transporter.
    Narayanan S; Gujarati NA; Wang JQ; Wu ZX; Koya J; Cui Q; Korlipara VL; Ashby CR; Chen ZS
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells.
    Kawabata S; Oka M; Shiozawa K; Tsukamoto K; Nakatomi K; Soda H; Fukuda M; Ikegami Y; Sugahara K; Yamada Y; Kamihira S; Doyle LA; Ross DD; Kohno S
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1216-23. PubMed ID: 11162657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity.
    Robey RW; Honjo Y; Morisaki K; Nadjem TA; Runge S; Risbood M; Poruchynsky MS; Bates SE
    Br J Cancer; 2003 Nov; 89(10):1971-8. PubMed ID: 14612912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel 7-modified camptothecin analog overcomes breast cancer resistance protein-associated resistance in a mitoxantrone-selected colon carcinoma cell line.
    Perego P; De Cesare M; De Isabella P; Carenini N; Beggiolin G; Pezzoni G; Palumbo M; Tartaglia L; Pratesi G; Pisano C; Carminati P; Scheffer GL; Zunino F
    Cancer Res; 2001 Aug; 61(16):6034-7. PubMed ID: 11507048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.